| Project Acronym | PRECISEU |
|---|---|
| Funding Programme | Horizon Europe - Interconnected Innovation Ecosystems cofund |
| Budget | € 11,340,050.00 |
| Coordinator | Biocat La Fundacio Bioregio De Catalunya (ES) |
| Website | https://preciseu.eu/ |
| Project duration | 1 July 2024 – 30 June 2029 |
About PRECISEU
The purpose of the PRECISEU project is connecting innovation ecosystems across Europe to efficiently advance towards a truly personalised healthcare, transferring practices and solutions from region to region and scaling up deep-tech healthcare innovations based on advanced therapies medicinal products (ATMPs) and health data across Europe.
The project outcomes will increase the efficiency of regional innovation ecosystems through strengthened collaboration and shared resources on strategic areas of regional strength and specialisation, enabling the development and implementation of innovative initiatives, and facilitating the digital and sustainable transformation of the healthcare systems.
The project aims to:
- Accelerate the adoption of personalised medicine (PM) at a European level;
- Reduce fragmentation and inequalities across the EU;
- Support the implementation deep-tech innovation in diverse ecosystems with different innovation levels, assets, strategies, and policies.
PRECISEU consortium
The institutions involved in the PRECISEU consortium are aware of challenges and barriers hampering PM’s full integration into healthcare systems, and aims at facing them with the cooperation of key regional stakeholders, contributing to the alignment of regional, national, and EU policies and funding instruments.
The project consortium represents 25 partners from 12 regions, belonging to 10 Member States including Spain, Germany, Belgium, Bulgaria, Rumania, Italy, Lithuania, Sweden, Netherlands and Greece, and to one HE associated country, Ukraine, including the involvement of representatives of regional authorities, healthcare and deep-tech clusters, research infrastructures, industry players, patients and entrepreneurial networks capable of activating added value collaborations across the entire European marketplace.
EATRIS’ role in the project
EATRIS will lead the activities of WP5 – multi-stakeholder infrastructure to enable access to ATMP on large scale that is focused on, for example, identifying bottlenecks and facilitating access to European ATMP infrastructure and resources and adding visibility to ATMP infrastructure in Europe and facilitate the exchange of knowledge and ideas within the EU ATMP landscape, by connecting stakeholders and current available infrastructures to facilitate translation to the clinic.
EATRIS will contribute to:
- The development of a multi-stakeholder infrastructure for ATMPs that will provide greater access, services and training to optimise ATMPs development from production to implementation in Europe;
- A detailed state-of-art mapping of existing regional ATMPs Hubs, technology owners and knowledge, from development to production, and from safety to regulations that support wider patient access is essential to create a first-of-its kind harmonised infrastructure to support innovative ATMP development, production, and implementation in the EU.
EATRIS will be also involved in the following work packages:
- WP3 – Connecting, complementing, and bridging to foster the connection between regions, reduce cooperation barriers and share capabilities and best practices on Health Data, Advanced Therapies and Personalised Medicine.
- WP4 – Use of Health-related Data focusing on the definition of recommendations and suggestions for the development of Joint Interregional Projects on Personalised Medicine;
- WP6 – Market and Patient Access aiming at developing of a robust infrastructure/model well established for open innovation within precision care across the EU (Industry, SMEs, HealthCare and Research).
